Abstract
Necrolytic migratory erythema is an obligatory paraneoplastic syndrome. Here we describe a patient with a neuroendocrine tumor of probably pancreatic origin. She developed the typical skin lesions under chemotherapy with temozolomide and capecitabine. © 2013 The Japanese Society of Internal Medicine.
Author supplied keywords
Cite
CITATION STYLE
APA
Gronau, M., Jäger, D., Enk, A. H., & Hassel, J. C. (2013). Necrolytic migratory erythema in a patient with neuroendocrine carcinoma. Internal Medicine, 52(1), 151–152. https://doi.org/10.2169/internalmedicine.52.8499
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free